BioTech Pharma
SNAP-8 research vial

2D Molecular Structure

SNAP-8 2D molecular structure for compound 71587832
CID
71587832
Standard InChIKey
QGGBBQJHVCVVKM-XOBYPWAZSA-N
FDA UNII
8K14HJF88S
Residue Count
8 AA
Structural Modifications
  • N-terminal acetyl
  • C-terminal amide
  • Contains oxidation-sensitive Met
cosmetic Research

SNAP-8

Also known as: Acetyl Octapeptide-3, Acetyl Glutamyl Heptapeptide-3

Acetylated octapeptide (Acetyl Octapeptide-3) derived from the SNAP-25 N-terminus, studied as a reference material in SNARE-biology research.
CAS Number
868844-74-0
Molecular Formula
C42H72N16O15S
Molecular Weight
1073.2 g/mol
Purity
Batch-specific
Form
Lyophilized powder
Enquiry Sizes
Research vial • Bulk / custom fill (quote required)
Peptide Sequence8 residues
Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2

Compliance Notice: All products supplied by BioTech Pharma are intended strictly for laboratory research and development use only. They are not intended for human or veterinary use, diagnosis, treatment, or consumption of any kind. By submitting an enquiry, the requester confirms they are a qualified researcher or institution and accepts full responsibility for compliant handling and use.

Configure Your Request

Documentation requests are reviewed against the records available for the applicable lot. Availability, methods, and values must be confirmed for the specific enquiry and are not promised in advance.

Form supplied: Lyophilized powder. Your selections are carried into the quote request automatically.

Overview

SNAP-8, known by the INCI name Acetyl Octapeptide-3, is a synthetic, N-acetylated and C-terminally amidated octapeptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2). Its sequence is modeled on the N-terminal region of SNAP-25, a component of the SNARE complex involved in neurotransmitter-vesicle docking, which is why it has been studied in the published literature as a probe of that pathway.

In research settings the peptide is studied as a reference material in SNARE-complex assembly assays in cell-free and in-vitro systems. Reported effects on SNARE-mediated exocytosis are model observations that characterize a molecular pathway; they do not establish clinical efficacy and are described here only as published research context.

BioTech Pharma supplies SNAP-8 as a lyophilized powder for in-vitro research use only; it is not a drug and is not intended for topical, cosmetic, human, or veterinary use. The sequence contains an oxidation-sensitive methionine residue. Lot-specific analytical documentation may be available and should be confirmed for the applicable material.

Research Applications

  • SNARE-complex assembly studies (in vitro)
  • Peptide oxidation and methionine-stability chemistry
  • Analytical method development (LC-MS/HPLC)

Frequently Asked Questions

Scientific References

Analytical Data

Lot-specific documentation may be available for the applicable material and must be confirmed per enquiry. Where available, it may include:

  • HPLC purity result
  • LC-MS identity confirmation
  • Appearance
  • Net content

Request the records you need with your quote and we will confirm availability for your batch.

Procurement Details

Availability, lead time, salt / content basis, and cold-chain requirements depend on the specific lot and quantity, so we confirm them per enquiry rather than publishing fixed figures. Request confirmation for your requirements with your quote and our team will respond with details for the applicable batch.

Storage & Handling

Lyophilized: store at −20 °C, protected from light and moisture; the methionine residue is oxidation-sensitive, so limit air exposure. Reconstituted: store cold and protected from light, minimizing headspace exposure; confirm prepared-solution stability for the applicable material before extended use.

Related Compounds